drugset / Trial / NCT01570582
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NaSingle-groupOpen-labelTreatment
Summary
purpose Primary endpoint * To evaluate the 24 month disease free survival Second endpoints * To evaluate the 24 month overall survival To analyze the toxicity and the quality of life
Timeline
- Start
- 2010-03
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | — | — |
| Background | Carboplatin | Small molecule | — | — |